CareTrust REIT (CTRE) Stock May Still Be A Bargain Despite $291 Million Investment News

CareTrust REIT has delivered a strong 131.3% total return over the past 5 years, yet the current valuation checks and recent share price pullback invite a closer look at whether the stock still offers good value after that run.

• Over 5 years, a 131.3% return places CareTrust REIT among the stronger performers, which can reduce the margin of safety if earnings and cash flow do not keep pace.
• The recent announcement of US$291 million in new investments and a US$1.5b year to date total may support long term growth. At the same time, committing significant capital to a US$540 million pipeline also adds execution and integration risk for future returns.
• The stock screens as undervalued on earnings based multiples, but a mixed overall result, with CareTrust REIT passing 4 out of 6 valuation checks on these measures, points to neither a clear bargain nor an obvious overvaluation.

The issue now is whether the recent rally in CareTrust REIT has already priced in these investment plans or if the current share price still leaves room for further upside on a valuation basis.

Find out why CareTrust REIT's 23.1% return over the last year is lagging behind its peers.

Is CareTrust REIT a Bargain on Earnings?

P/E suits a company like CareTrust REIT because earnings are a key anchor for a mature, income focused REIT. CareTrust REIT currently trades on a P/E of about 26.0x, which sits above the Health Care REITs sector average of roughly 17.0x but below the broader peer group average of about 62.2x. That means the stock is priced richer than the typical sector peer, yet not at the higher levels seen across some comparable companies.

The fair P/E ratio implied by the model is 43.4x, which reflects what investors might pay for CareTrust REIT given its size, risk profile and earnings outlook. Against that benchmark, the current 26.0x P/E sits at a discount, even after the recent announcement of US$291 million of new investments and a US$1.5b year to date total that has kept attention on the stock. The gap between the fair ratio and the current multiple points to a market price that does not fully align with what this framework suggests.

On the P/E multiple, CareTrust REIT stock currently appears undervalued relative to the earnings based fair ratio implied by this model.

See what the numbers say about this price — find out in our valuation breakdown.

The CareTrust REIT Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for CareTrust REIT pick up where the P/E discussion leaves off and explain which possible paths for CareTrust REIT's growth, margins and earnings would need to occur for the stock to be worth materially more or less than today's price. Instead of only giving you a single number from a model, they describe the set of assumptions behind that figure so you can observe how the real world develops over time. These are available on Simply Wall St's Community page.

You can be one of the early voices in the Simply Wall St community to set out a number driven narrative on CareTrust REIT's recent US$291 million of investments and US$1.5b year to date activity, and how that could shape the stock from here. Share your view, track how it holds up as new results and pipeline updates come through, and see how other investors respond.

Do you think there's more to the story for CareTrust REIT? Head over to our Community to see what others are saying!

The Bottom Line

CareTrust REIT screens as undervalued on its current P/E relative to the modelled fair ratio, yet the broader set of checks only gives a mixed signal rather than a clear green light. The stock now sits in a zone where valuation is no longer the only story. The key question is whether CareTrust REIT can turn its sizeable recent and planned investment activity into steady earnings that justify even a modest re rating of the multiple, or whether the market is already correctly discounting the execution risk in that pipeline.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com